[Federal Register Volume 89, Number 183 (Friday, September 20, 2024)]
[Notices]
[Pages 77155-77156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21497]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Board on Radiation and Worker Health,
Subcommittee for Procedure Reviews, National Institute for Occupational
Safety and Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Subcommittee on Procedures Reviews (SPR) of
the Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board). This meeting is open to the public, but without a
public comment period. The public is welcome to submit written comments
in advance of the meeting, to the contact person below. Written
comments received in advance of the meeting will be included in the
official record of the meeting. The public is also welcomed to listen
to the meeting by joining the audio conference (information below). The
audio conference line has 150 ports for callers.
DATES: The meeting will be held on November 8, 2024, from 11 a.m. to
4:30 p.m., EST. Written comments must be received on or before November
1, 2024.
ADDRESSES: You may submit comments by mail to: Rashaun Roberts, Ph.D.,
National Institute for Occupational Safety and Health, Centers for
Disease Control and Prevention, 1090 Tusculum Avenue, MS C-24,
Cincinnati, Ohio 45226.
Meeting Information: Audio Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1-866-659-0537; the pass code is
9933701.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention, 1090 Tusculum Avenue,
Mailstop C-24, Cincinnati, Ohio 45226, Telephone: (513) 533-6800, Toll
Free 1(800) CDC-INFO, Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC.
The charter was issued on August 3, 2001, renewed at appropriate
intervals, and rechartered under Executive Order 14109 (September 29,
2023) on March 22, 2024. Unless continued by the President the Board
will terminate on
[[Page 77156]]
September 30, 2025, consistent with E.O. 14109 (September 29, 2023).
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. The ABRWH
Subcommittee on Procedure Reviews (SPR) is responsible for overseeing,
tracking, and participating in the reviews of all procedures used in
the dose reconstruction process by the NIOSH Division of Compensation
Analysis and Support (DCAS) and its dose reconstruction contractor (Oak
Ridge Associated Universities--ORAU).
Matters to be Considered: The meeting agenda will include
discussions on the following: (1) Carry-over items from March 14, 2024
SPR meeting, including a. DCAS-PER-040 ``Mallinckrodt TBD Revisions,''
b. DCAS-PER-068 ``Electro Metallurgical Co'', c. DCAS-PER-070 ``Nuclear
Metals Inc.'', d. DCAS-PER-072 ``Seymour Specialty Wiring Co'', e.
ORAUT-RPRT-0060 ``Neutron Dose from Highly Enriched Uranium'', and f.
DR template reviews--findings versus observations; (2) Newly issued
SC&A reviews, including a. ORAUT-OTIB-0036 ``Internal Dosimetry
Coworker Data for Portsmouth Gaseous Diffusion Plant'' b. ORAUT-OTIB-
0040 ``External Coworker Dosimetry Data for the Portsmouth Gaseous
Diffusion Plant'' c. ORAUT-OTIB-0093 ``Conversion of Committed
Effective Dose to Annual Organ Dose'' and d. ORAUT-RPRT-0087
``Applications of Regression in External Dose Reconstruction''; (3)
Preparation for August 2024 Full ABRWH Meeting: Review of technical
guidance documents ready for full Board approval; (4) Newly Issued
Guidance and Supplemental Topics. Agenda items are subject to change as
priorities dictate. For additional information, please contact Toll
Free 1(800) 232-4636.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-21497 Filed 9-19-24; 8:45 am]
BILLING CODE 4163-18-P